You are here


FDA codified an expedited review pathway for breakthrough-designated drugs in a manual of policies and procedures (MAPP) released this week, instructing FDA review teams to act at least one month... Read more
New Whitepaper Released on Next-Generation Sequencing (NGS) in OncologyAhead of FDA's Workshop on NGS, Friends of Cancer Research is Releasing the Final Whitepaper from our September 2014... Read more
Dr. Margaret Hamburg, who as commissioner of the U.S. Food and Drug Administration (FDA) for almost six years has overseen public health initiatives ranging from tobacco control and food safety to... Read more
As Dr. Hamburg steps down as Commissioner, we are deeply indebted to her for all she has done for science and for patientsWashington, DC, February 5, 2015 - Friends of Cancer Research would like to... Read more
Days after the White House announced a new precision-medicine initiative, an influential group of US lawmakers has released its own wish list for biomedical research. On 27 January, several members... Read more
Representatives from the pharmaceutical and biotechnology industries said last Friday (Dec. 12) they expect work on the bipartisan 21st Century Cures initiative this spring to be a staging ground for... Read more
More than 60% of US prescriptions for cancer drugs call for using the medicines in ways that are not approved by the government. Often, they are the only hope against a fatal illness that has... Read more
Medicare officials are evaluating new approaches to finding the most effective cures for cancer.Researchers developing more targeted therapies are anxious to see whether cancer drugs approved for use... Read more
The Bonnie J. Addario Lung Cancer Foundation (ALCF), in collaboration with Foundation Medicine and Friends of Cancer Research, and in partnership with many advocacy organizations, today launched the... Read more
FDA’s biologics center grants accelerated approval to the first U.S. vaccine targeting serogroup B meningococcal disease after a 4.5-month review; the vaccine is expected to come up for discussion,... Read more